USE OF UROKINASE GENE AMPLIFICATION AS A MARKER

摘要

The present invention relates to the use of urokinase gene amplification as a marker for evaluating the treatment sensitivity and specificity of carcinomas, especially invasive forms of carcinomas, and in particular invasive forms of hormone-dependent cancers, such as prostate cancer and breast cancer. The present invention also relates to methods of identification of carcinomas profiled by urokinase gene amplification.